Quest Diagnostics · 2 days ago
Cardio Kidney Metabolic Account Executive
Quest Diagnostics is a leading provider of diagnostic information services, and they are seeking a Cardio Kidney Metabolic Account Executive to drive sales in the specialized testing market. This role involves collaborating with physician and hospital account executives to support a collaborative selling model and requires daily travel throughout Oregon and parts of Idaho.
BiotechnologyHealth CareHealth DiagnosticsInformation ServicesPrecision Medicine
Responsibilities
Drive sales in assigned territories through upselling of existing accounts, new lead generation, referrals and establishing relationships with prospective customers
Target and close new specialty testing opportunities
Responsible for working directly with assigned Account Executives in the assigned district
Partner with and notify Hospital or Physician Representative of complex issues or when full-touch service is required
Provide immediate support for less complex issues
Provide subject matter expertise for associated specialty testing
Maintain and pursue knowledge in associated specialist testing area
Maintain a breadth of knowledge of all connectivity products (i.e. Quanum, e-orders, e-prescribe)
Prepare and present proposals and bids
Ensure compliance with company policies and government regulations
Complete all administrative tasks thoroughly and promptly
Qualification
Required
Bachelor's Degree
Candidate must have residency in close proximity of territory
Three or more years of sales experience in selling business to business with a history of documented sales success
Prior responsibility for closing new business and expanding existing relationships
Preferred
Prefer experience in healthcare, laboratory and/or diagnostics sales selling to medical professionals
Company
Quest Diagnostics
Quest Diagnostics is a clinical laboratory that offers diagnostic testing, services, and information.
Funding
Current Stage
Public CompanyTotal Funding
$2.6B2024-08-15Post Ipo Debt· $1.85B
2023-10-30Post Ipo Debt· $750M
1996-12-17IPO
Leadership Team
Recent News
DBusiness Magazine
2026-02-05
Medical Device Network
2026-02-03
Company data provided by crunchbase